17.21
溶酶体是在膜运输过程(例如分泌、内吞、自噬和吞噬途径)中释放的大分子和生物聚合物进行降解的场所。溶酶体的膜封闭区域称为腔,其中含有在酸性环境中活跃的水解酶。这些酸性水解酶能够在 pH 值为 4.5 至 5 之间发挥作用,并同时还会参与到细胞信号传导、能量代谢、细胞质膜恢复、排出物质计数等细胞过程。
…
溶酶体含有多种酶,有助于降解大分子。
这些酶在 pH 值为 5 的酸性环境中活性最佳,利用水分子断裂其底物中的化学键。因此,溶酶体酶被称为酸性水解酶。
溶酶体水解酶在粗面内质网中合成,随后被转运至高尔基体。在高尔基体中,这些水解酶的N-连接寡糖上会被添加甘露糖-6-磷酸基团(M6P),从而标记这些酶。
跨膜受体特异性识别M6P标记物,并将水解酶锚定在膜的腔面一侧,而网格蛋白包被则在细胞质侧组装。
受体结合的酶以网格蛋白包被小泡的形式从反式高尔基体网络出芽,并转运至早期内体。
由于M6P受体在pH低于6的条件下无法与水解酶结合,内体的酸性pH促使酶在内体腔内释放。
早期内体成熟为晚期内体,并与溶酶体融合,将酶递送至其最终目的地——内溶酶体。
View the full transcript and gain access to JoVE Core videos
Q1: What are lysosomal hydrolases and what do they do?
Lysosomal hydrolases are acid hydrolases—enzymes that degrade macromolecules inside lysosomes. These enzymes are optimally active at an acidic pH between 4.5 and 5, where they use water molecules to break down chemical bonds in their substrates. They function in cellular processes including energy metabolism, cell signaling, and restoration of the plasma membrane.
Q2: How are lysosomal hydrolases synthesized and transported to lysosomes?
Lysosomal hydrolases are produced in the rough endoplasmic reticulum and transported to the Golgi apparatus. In the Golgi, they are tagged with Mannose-6-Phosphate (M6P) groups added to N-linked oligosaccharides. Transmembrane receptors recognize M6P markers, anchoring the hydrolases on the membrane lumenal side while clathrin coats assemble on the cytosolic side, forming clathrin-coated vesicles that bud from the trans-Golgi network.
Q3: Why does the acidic pH of the endosome cause hydrolase release?
M6P receptors cannot bind hydrolases at pH lower than 6. When clathrin-coated vesicles reach the early endosome, its acidic pH prevents receptor-enzyme binding, causing the hydrolases to release into the endosomal lumen. The early endosome then matures to the late endosome and fuses with the lysosome, delivering enzymes to their final destination.
Q4: What causes lysosomal storage diseases?
Lysosomal storage diseases result from genetic defects in lysosomal function, causing absence or deficiency of specific hydrolytic enzymes. Without functional enzymes, undigested molecules accumulate in the lysosome. This substrate accumulation causes organelle swelling and irreversible cellular damage. More than 40 such diseases are known, affecting approximately one in every 8,000 infants.
Q5: What happens in I-cell disease?
I-cell disease, or inclusion-cell disease, is a severe lysosomal storage disorder caused by a recessive single gene defect. Lysosomes lack most hydrolytic enzymes, leading to massive accumulation of undigested substrates. This creates large cellular inclusions that pathologically affect all organ systems, skeletal integrity, and mental development, making it one of the most severe forms of lysosomal storage disease.
Q6: How do specific enzyme deficiencies lead to different lysosomal storage diseases?
Different lysosomal storage diseases result from deficiencies in specific enzymes. Tay-Sachs occurs when N-hexosaminidase, which degrades gangliosides, is deficient. Hurler's disease involves defective glycosaminoglycan breakdown enzymes. Pompe disease results from glucosidase absence, causing glycogen accumulation and fatal organelle swelling. Each enzyme deficiency produces distinct substrate accumulation patterns and disease symptoms.
Q7: What role do M6P markers play in lysosomal hydrolase targeting?
Mannose-6-Phosphate (M6P) markers are recognition tags added to hydrolase oligosaccharides in the Golgi apparatus. Transmembrane receptors specifically recognize M6P groups, anchoring enzymes to the membrane and directing them into clathrin-coated vesicles. This M6P-receptor interaction ensures hydrolases are properly sorted and delivered to lysosomes through the endosomal pathway.